Riyadh – Sharikat Mubasher: Sarat Ventures Y Innovations Biotech Fund (UK) announced the launch of a $50 million biotech investment fund anchored by Allocator One, with a focus on companies tied to Saudi Arabia and the wider MENA region.
The move marks a significant step toward positioning the Kingdom as a biotechnology hub in line with Vision 2030’s diversification goals, as per a recent press release.
The fund is led by Dr. Megan Yung of Yung Ventures, part of Y Innovations Group, and Dr. Huda Alfardus, formerly of Healthgena, Saudi Arabia’s first private accelerator. Together, they bring global biotech expertise and strong regional connections to support portfolio companies entering the Saudi market.
The initiative will leverage Y Innovations Group’s track record in life sciences, including early-stage biotech growth, commercialization, and exits. With Saudi Arabia’s biotechnology sector projected to reach $11–12 billion by 2030, the fund aims to accelerate innovation in therapeutics and strengthen the Kingdom’s emerging life sciences ecosystem.
